SECTOR / TELECOM AND MEDIA

Raise ARPU without buying churn.

For audience insights, subscription strategy, and pricing teams: test price, bundle, ad tier, and content bets before they ship. Subconscious turns one plausible forecast into thousands of measured subscriber experiments.

4.6%

Premium SVOD churn stabilized around a level where every price move matters. The upside is not cheaper research. It is knowing which offer lifts ARPU without pushing the wrong subscribers out.

Source: Antenna, Premium SVOD 2025 Year in Review

THE TIMING SHIFT

Today
  1. Price
  2. Bundle
  3. Ad tier
  4. First bill
  5. Churn read
Subconscious
  1. Price
  2. Bundle
  3. Ad tier
  4. First bill
  5. Churn read
Current teams learn after cancellations. Subconscious tests the tradeoff before customers see the offer.

CAUSAL OPERATING LOOP

KPI shift

ARPU up, churn protected.

ARPU lift

Price changes are judged after customers react.

Price, bundle, and ad load are ranked before rollout.

Retention guardrail

Cancellation patterns explain the damage later.

Churn risk is modeled before the offer ships.

Content leverage

Programming bets compete with price noise.

Content, offer, and creative are tested on the same cohort.

Relative decision leverage. Every read ships with cohort, confidence interval, and experiment trail.
Telecom and media causal decision graphSubscriber tenure and engagement confound the relationship between price, bundle, and ad decisions and ARPU, churn, and LTV outcomes. Subconscious isolates the causal effect.Utenure / engagementunobserveddo(O)price / bundle / ad loadYARPU / churn / LTV
Grey arrows are the correlations hiding in the subscriber file. The red arrow is the causal effect of price, bundle, and ad load on ARPU, churn, and lifetime value.

ONE CAUSAL ANSWER

Which offer raises revenue without training customers to leave?

Walk into the pricing committee with the offer stack ranked: which price to raise, which bundle to protect, which ad load to cap, and which content audience can take the move.

PROOF

93%

validated against human outcomes

350+

replicated human studies

5 min

to run the next decision

SOC 2

enterprise-ready deployment